Nootropics Market Size, Share & Trends Analysis Report By Form (Capsules/Tablets, Powder, Drinks), By Distribution Channel (Offline, Online), By Region, And Segment Forecasts, 2021 - 2028
This report can be delivered to the clients within 72 Business Hours
Nootropics Market Growth & Trends
The global nootropics market size is expected to reach USD 29.24 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.0% from 2021 to 2028. Nootropics are gaining popularity as cognitive enhancers and smart drugs as these are particularly used for improving memory, increasing mental alertness and concentration, and boosting energy levels and wakefulness. According to an article published by the Alcohol and Drug Association (ADF), in November 2021, CILTEP and Alpha Brain are the most used nootropic supplements among young consumers.
The growing availability of over-the-counter (OTC) nootropics, nootropics coffee, functional shots, and bars across online and offline channels is driving the consumption of nootropics. Further, shifting inclination towards natural and herbal products has been playing a vital role in boosting the market growth. Some of the commonly found herbs in nootropics include ginkgo Biloba, ginseng, curcumin, echinacea, L-theanine from green tea, turmeric, guarana, and bilberry.
The capsules/tablets segment held the largest revenue share in 2020 and is expected to maintain its lead over the forecast period. The consumption of capsules/tablets is the most convenient way to take supplements, which is expected to continue throughout the forecast period, thereby boosting the segment growth.
The offline segment held the largest revenue share in 2020 and is expected to maintain its lead throughout the forecast period. Offline channels are the primary channels for purchasing these products. These include major supermarket and hypermarket chains, pharmacies and drugstores, and grocery stores. An increasing number of consumers rely on these stores for buying nootropics including bars, coffee, and functional drinks due to the large availability of brands. The market for nootropics is consolidated owing to the presence of a large number of leading players.
Nootropics Market Report Highlights
Nootropics Market Growth & Trends
The global nootropics market size is expected to reach USD 29.24 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.0% from 2021 to 2028. Nootropics are gaining popularity as cognitive enhancers and smart drugs as these are particularly used for improving memory, increasing mental alertness and concentration, and boosting energy levels and wakefulness. According to an article published by the Alcohol and Drug Association (ADF), in November 2021, CILTEP and Alpha Brain are the most used nootropic supplements among young consumers.
The growing availability of over-the-counter (OTC) nootropics, nootropics coffee, functional shots, and bars across online and offline channels is driving the consumption of nootropics. Further, shifting inclination towards natural and herbal products has been playing a vital role in boosting the market growth. Some of the commonly found herbs in nootropics include ginkgo Biloba, ginseng, curcumin, echinacea, L-theanine from green tea, turmeric, guarana, and bilberry.
The capsules/tablets segment held the largest revenue share in 2020 and is expected to maintain its lead over the forecast period. The consumption of capsules/tablets is the most convenient way to take supplements, which is expected to continue throughout the forecast period, thereby boosting the segment growth.
The offline segment held the largest revenue share in 2020 and is expected to maintain its lead throughout the forecast period. Offline channels are the primary channels for purchasing these products. These include major supermarket and hypermarket chains, pharmacies and drugstores, and grocery stores. An increasing number of consumers rely on these stores for buying nootropics including bars, coffee, and functional drinks due to the large availability of brands. The market for nootropics is consolidated owing to the presence of a large number of leading players.
Nootropics Market Report Highlights
- Asia Pacific is projected to register the fastest growth rate over the forecast period owing to the prevalence of mental health problems, such as stress, anxiety, and depression. The COVID-19 pandemic has significantly contributed to the rising stress levels and poor cognitive health, which has led to an increase in a person’s vulnerability to disease and illness, thereby driving the consumption of nootropics in the region
- The drinks form segment is projected to register the fastest CAGR of 16.0% from 2021 to 2028. The consumption of functional beverages has become an emerging trend among consumers, which is driving the segment
- The online distribution channel segment is expected to witness the fastest growth during the forecast period. Consumers are buying nootropics online owing to the increasing prevalence of e-commerce and rising internet penetration, which has been boosting the segment growth
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Form Outlook
2.3. Distribution channel Outlook
2.4. Regional Outlook
2.5. Competitive Insights
CHAPTER 3. NOOTROPICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Introduction
3.2. Penetration & Growth Prospect Mapping
3.3. Impact of COVID-19 on the Nootropics Market
3.4. Industry Value Chain Analysis
3.4.1. Sales/Retail Channel Analysis
3.4.2. Profit Margin Analysis
3.5. Market Dynamics
3.5.1. Driver Impact Analysis
3.5.2. Restraint Impact Analysis
3.5.3. Industry Challenges
3.5.4. Industry opportunities
3.6. Business Environment Analysis
3.6.1. Industry Analysis – Porter’s Five Forces
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat from New Entrant
3.6.1.5. Competitive Rivalry
3.7. Roadmap of Nootropics Market
3.8. Market Entry Strategies
CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS
4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Product Adoption
4.5. Observations & Recommendations
CHAPTER 5. NOOTROPICS MARKET: FORM ESTIMATES & TREND ANALYSIS
5.1. Form Movement Analysis & Market Share, 2020 & 2028
5.2. Capsules/Tablets
5.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.3. Powder
5.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.4. Drinks
5.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.5. Others
5.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
CHAPTER 6. NOOTROPICS MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Distribution channel Movement Analysis & Market Share, 2020 & 2028
6.2. Offline
6.2.1. Market estimates and forecast through offline channel, 2016 - 2028 (USD Million)
6.3. Online
6.3.1. Market estimates and forecast through online channel, 2016 - 2028 (USD Million)
CHAPTER 7. NOOTROPICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Movement Analysis & Market Share, 2020 & 2028
7.2. North America
7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.2.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.2.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.2.4. U.S.
7.2.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.2.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.2.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.3. Europe
7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.3.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.3.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.3.4. Germany
7.3.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.3.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.3.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.3.5. Italy
7.3.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.3.5.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.3.5.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.4. Asia Pacific
7.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.4.4. China
7.4.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.4.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.4.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.4.5. India
7.4.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.4.5.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.4.5.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.5. Central & South America
7.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.5.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.5.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.5.4. Brazil
7.5.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.5.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.5.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.6. Middle East & Africa
7.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.6.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.6.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.6.4. UAE
7.6.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.6.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.6.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
CHAPTER 8. COMPETITIVE ANALYSIS
8.1. Key global players, recent developments & their impact on the industry
8.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. Key company market share analysis, 2020
CHAPTER 9. COMPANY PROFILES
9.1. Onnit Labs
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Reckitt Benckiser Group plc.
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Strategic Initiatives
9.3. Mental Mojo, LLC
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Strategic Initiatives
9.4. NooCube
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Strategic Initiatives
9.5. Mind Lab Pro
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Strategic Initiatives
9.6. TruBrain
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Strategic Initiatives
9.7. Neu Drinks
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Strategic Initiatives
9.8. Peak Nootropics
9.8.1. Company Overview
9.8.2. Product Benchmarking
9.8.3. Strategic Initiatives
9.9. Zhou Nutrition
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Strategic Initiatives
9.10. Kimera Koffee
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Form Outlook
2.3. Distribution channel Outlook
2.4. Regional Outlook
2.5. Competitive Insights
CHAPTER 3. NOOTROPICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Introduction
3.2. Penetration & Growth Prospect Mapping
3.3. Impact of COVID-19 on the Nootropics Market
3.4. Industry Value Chain Analysis
3.4.1. Sales/Retail Channel Analysis
3.4.2. Profit Margin Analysis
3.5. Market Dynamics
3.5.1. Driver Impact Analysis
3.5.2. Restraint Impact Analysis
3.5.3. Industry Challenges
3.5.4. Industry opportunities
3.6. Business Environment Analysis
3.6.1. Industry Analysis – Porter’s Five Forces
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat from New Entrant
3.6.1.5. Competitive Rivalry
3.7. Roadmap of Nootropics Market
3.8. Market Entry Strategies
CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS
4.1. Demographic Analysis
4.2. Consumer Trends and Preferences
4.3. Factors Affecting Buying Decision
4.4. Consumer Product Adoption
4.5. Observations & Recommendations
CHAPTER 5. NOOTROPICS MARKET: FORM ESTIMATES & TREND ANALYSIS
5.1. Form Movement Analysis & Market Share, 2020 & 2028
5.2. Capsules/Tablets
5.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.3. Powder
5.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.4. Drinks
5.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
5.5. Others
5.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
CHAPTER 6. NOOTROPICS MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
6.1. Distribution channel Movement Analysis & Market Share, 2020 & 2028
6.2. Offline
6.2.1. Market estimates and forecast through offline channel, 2016 - 2028 (USD Million)
6.3. Online
6.3.1. Market estimates and forecast through online channel, 2016 - 2028 (USD Million)
CHAPTER 7. NOOTROPICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Movement Analysis & Market Share, 2020 & 2028
7.2. North America
7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.2.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.2.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.2.4. U.S.
7.2.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.2.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.2.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.3. Europe
7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.3.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.3.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.3.4. Germany
7.3.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.3.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.3.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.3.5. Italy
7.3.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.3.5.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.3.5.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.4. Asia Pacific
7.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.4.4. China
7.4.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.4.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.4.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.4.5. India
7.4.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.4.5.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.4.5.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.5. Central & South America
7.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.5.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.5.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.5.4. Brazil
7.5.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.5.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.5.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.6. Middle East & Africa
7.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.6.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.6.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
7.6.4. UAE
7.6.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.6.4.2. Market estimates and forecast, by form, 2016 - 2028 (USD Million)
7.6.4.3. Market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
CHAPTER 8. COMPETITIVE ANALYSIS
8.1. Key global players, recent developments & their impact on the industry
8.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. Key company market share analysis, 2020
CHAPTER 9. COMPANY PROFILES
9.1. Onnit Labs
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Strategic Initiatives
9.2. Reckitt Benckiser Group plc.
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Strategic Initiatives
9.3. Mental Mojo, LLC
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Strategic Initiatives
9.4. NooCube
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Strategic Initiatives
9.5. Mind Lab Pro
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Strategic Initiatives
9.6. TruBrain
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Strategic Initiatives
9.7. Neu Drinks
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Strategic Initiatives
9.8. Peak Nootropics
9.8.1. Company Overview
9.8.2. Product Benchmarking
9.8.3. Strategic Initiatives
9.9. Zhou Nutrition
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Strategic Initiatives
9.10. Kimera Koffee
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Strategic Initiatives
LIST OF TABLES
1. Nootropics market - Driving factor impact analysis
2. Nootropics market - Restraint factor impact analysis
3. Capsules/tablets market estimates and forecast, 2016 - 2028 (USD million)
4. Powder market estimates and forecast, 2016 - 2028 (USD million)
5. Drinks market estimates and forecasts, 2016 - 2028 (USD million)
6. Others market estimates and forecasts, 2016 - 2028 (USD million)
7. Nootropics market estimates and forecasts through offline channel, 2016 - 2028 (USD million)
8. Nootropics market estimates and forecasts through online channel, 2016 - 2028 (USD million)
9. North America nootropics market estimates and forecast, 2016 - 2028 (USD Million)
10. North America nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
11. North America nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
12. U.S. nootropics market estimates and forecast, 2016 - 2028 (USD Million)
13. U.S. nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
14. U.S. nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
15. Europe nootropics market estimates and forecast, 2016 - 2028 (USD Million)
16. Europe nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
17. Europe nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
18. Germany nootropics market estimates and forecast, 2016 - 2028 (USD Million)
19. Germany nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
20. Germany nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
21. Italy nootropics market estimates and forecast, 2016 - 2028 (USD Million)
22. Italy nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
23. Asia Pacific nootropics market estimates and forecast, 2016 - 2028 (USD Million)
24. Asia Pacific nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
25. Asia Pacific nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
26. China nootropics market estimates and forecast, 2016 - 2028 (USD Million)
27. China nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
28. China nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
29. India nootropics market estimates and forecast, 2016 - 2028 (USD Million)
30. India nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
31. India nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
32. Central & South America nootropics market estimates and forecast, 2016 - 2028 (USD Million)
33. Central & South America nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
34. Central & South America nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
35. Brazil nootropics market estimates and forecast, 2016 - 2028 (USD Million)
36. Brazil nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
37. Brazil nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
38. Middle East & Africa nootropics market estimates and forecast, 2016 - 2028 (USD Million)
39. Middle East & Africa nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
40. Middle East & Africa nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
41. UAE nootropics market estimates and forecast, 2016 - 2028 (USD Million)
42. UAE nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
43. UAE nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
44. Company categorization
1. Nootropics market - Driving factor impact analysis
2. Nootropics market - Restraint factor impact analysis
3. Capsules/tablets market estimates and forecast, 2016 - 2028 (USD million)
4. Powder market estimates and forecast, 2016 - 2028 (USD million)
5. Drinks market estimates and forecasts, 2016 - 2028 (USD million)
6. Others market estimates and forecasts, 2016 - 2028 (USD million)
7. Nootropics market estimates and forecasts through offline channel, 2016 - 2028 (USD million)
8. Nootropics market estimates and forecasts through online channel, 2016 - 2028 (USD million)
9. North America nootropics market estimates and forecast, 2016 - 2028 (USD Million)
10. North America nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
11. North America nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
12. U.S. nootropics market estimates and forecast, 2016 - 2028 (USD Million)
13. U.S. nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
14. U.S. nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
15. Europe nootropics market estimates and forecast, 2016 - 2028 (USD Million)
16. Europe nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
17. Europe nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
18. Germany nootropics market estimates and forecast, 2016 - 2028 (USD Million)
19. Germany nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
20. Germany nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
21. Italy nootropics market estimates and forecast, 2016 - 2028 (USD Million)
22. Italy nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
23. Asia Pacific nootropics market estimates and forecast, 2016 - 2028 (USD Million)
24. Asia Pacific nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
25. Asia Pacific nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
26. China nootropics market estimates and forecast, 2016 - 2028 (USD Million)
27. China nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
28. China nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
29. India nootropics market estimates and forecast, 2016 - 2028 (USD Million)
30. India nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
31. India nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
32. Central & South America nootropics market estimates and forecast, 2016 - 2028 (USD Million)
33. Central & South America nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
34. Central & South America nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
35. Brazil nootropics market estimates and forecast, 2016 - 2028 (USD Million)
36. Brazil nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
37. Brazil nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
38. Middle East & Africa nootropics market estimates and forecast, 2016 - 2028 (USD Million)
39. Middle East & Africa nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
40. Middle East & Africa nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
41. UAE nootropics market estimates and forecast, 2016 - 2028 (USD Million)
42. UAE nootropics market estimates and forecast, by form, 2016 - 2028 (USD Million)
43. UAE nootropics market estimates and forecast, by distribution channel, 2016 - 2028 (USD Million)
44. Company categorization
LIST OF FIGURES
1. Nootropics market segmentation
2. Information procurement
3. Primary research pattern
4. Primary research approaches
5. Primary research process
6. Nootropics market - Penetration & growth prospect mapping
7. Nootropics market - Value chain analysis
8. Profit margin analysis
9. Nootropics market: Porter’s Five Forces Analysis
10. Nootropics market: Roadmap
11. Factors affecting the buying decision for Nootropics market
12. Nootropics market: Form share (%) analysis, 2020 & 2028
13. Nootropics market: Distribution channel share (%) analysis, 2020 & 2028
14. Nootropics market: Regional share (%) analysis, 2020 & 2028
1. Nootropics market segmentation
2. Information procurement
3. Primary research pattern
4. Primary research approaches
5. Primary research process
6. Nootropics market - Penetration & growth prospect mapping
7. Nootropics market - Value chain analysis
8. Profit margin analysis
9. Nootropics market: Porter’s Five Forces Analysis
10. Nootropics market: Roadmap
11. Factors affecting the buying decision for Nootropics market
12. Nootropics market: Form share (%) analysis, 2020 & 2028
13. Nootropics market: Distribution channel share (%) analysis, 2020 & 2028
14. Nootropics market: Regional share (%) analysis, 2020 & 2028
